1 |
Vina D, Serra S, Lamela M, Delogu G. 2012. Herbal natural products as a source of monoamine oxidase inhibitors: a review. Curr. Top. Med. Chem. 12: 2131-2144.
DOI
|
2 |
Lee HW, Jung WK, Kim HJ, Jeong YS, Nam SJ, Kang H, Kim H. 2015. Inhibition of monoamine oxidase by anithiactins from Streptomyces sp. J. Microbiol. Biotechnol. 25: 1425-1428.
DOI
|
3 |
Lee IK, Yun BS, Oh S, Kim YH, Lee MK, Yoo ID. 1999. 5-Methylmellein and nectriapyrone, two new monoamine oxidase inhibitors. Med. Sci. Res. 27: 463-465.
|
4 |
Marin S, Ramos AJ, Cano-Sancho G, Sanchis V. 2013. Mycotoxins: occurrence, toxicology, and exposure assessment. Food Chem. Toxicol. 60: 218-237.
DOI
|
5 |
Ostry V. 2008. Alternaria mycotoxins: an overview of chemical characterization, producers, toxicity, analysis and occurrence in foodstuffs. World Mycotoxin J. 1: 175-188.
DOI
|
6 |
Scott PM, Zhao W, Feng S, Lau BP. 2012. Alternaria toxins alternariol and alternariol monomethyl ether in grain foods in Canada. Mycotoxin Res. 28: 261-266.
DOI
|
7 |
Zhang SY, Li ZL, Bai J, Wang Y, Zhang LM, Wu X, Hua HM. 2012. A new perylenequinone from a halotolerant fungus, Alternaria sp. M6. Chin. J. Nat. Med. 10: 68-71.
|
8 |
Legoabe LJ, Petzer A, Petzer JP. 2012. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives. Eur. J. Med. Chem. 49: 343-353.
DOI
|
9 |
Schwarz C, Tiessen C, Kreutzer M, Stark T, Hofmann T, Marko D. 2012. Characterization of a genetoxic impact compound in Alternaria alternata infected rice as altertoxin II. Arch. Toxicol. 86: 1911-1925.
DOI
|
10 |
Lee HW, Ryu HW, Kang MG, Park D, Oh SR, Kim H. 2016. Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens. Bioorg. Med. Chem. Lett. 26: 4714-4719
DOI
|
11 |
Petzer A, Harvey BH, Petzer JP. 2014. The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase. Toxicol. Appl. Pharmacol. 274: 488-493.
DOI
|
12 |
Petzer A, Pienaar A, Petzer JP. 2013. The inhibition of monoamine oxidase by esomeprazole. Drug Res. (Stuttg.). 63: 462-467.
DOI
|
13 |
Yamada M, Yasuhara H. 2004. Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology 25: 215-221.
DOI
|
14 |
Youdim MB, Edmondson D, Tipton KF. 2006. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci. 7: 295-309.
DOI
|
15 |
Mostert S, Petzer A, Petzer JP. 2015. Indanones as highpotency reversible inhibitors of monoamine oxidase. ChemMedChem. 10: 862-873.
DOI
|
16 |
Mattsson C, Svensson P, Sonesson C. 2014. A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors. Eur. J. Med. Chem. 73: 177-186.
DOI
|
17 |
Abdelhafez OM, Amin KM, Ali HI, Abdalla MM, Batran RZ. 2012. Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors. J. Med. Chem. 55: 10424-10436.
DOI
|
18 |
Fowler JS, Logan J, Azzaro AJ, Fielding RM, Zhu W, Poshusta AK, et al. 2010. Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAOA by CX157. Neuropsychopharmacology 35: 623-631.
DOI
|
19 |
Gentili F, Pizzinat N, Ordener C, Marchal-Victorion S, Maurel A, Hofmann R, et al. 2006. 3-[5-(4,5-Dihydro-1Himidazol-2-yl)-furan-2-yl]phenylamine (amifuraline), a promising reversible and selective peripheral MAO-A inhibitor. J. Med. Chem. 49: 5578-5586.
DOI
|
20 |
Kim H, Sablin SO, Ramsay RR. 1997. Inhibition of monoamine oxidase A by -carboline derivatives. Arch. Biochem. Biophys. 337: 137-142.
DOI
|
21 |
Berlin I, Zimmer R, Thiede HM, Payan C, Hergueta T, Robin L, Puech AJ. 1990. Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects. Br. J. Clin. Pharmacol. 30: 805-816.
DOI
|
22 |
Ramsay RR. 2012. Monoamine oxidases: the biochemistry of the proteins as targets in medicinal chemistry and drug discovery. Curr. Top. Med. Chem. 12: 2189-2209.
DOI
|
23 |
Dolle F, Valette H, Bramoulle Y, Guenther I, Fuseau C, Coulon C, et al. 2003. Synthesis and in vivo imaging properties of [11C]befloxatone: a novel highly potent positron emission tomography ligand for mono-amine oxidase-A. Bioorg. Med. Chem. Lett. 13: 1771-1775
DOI
|
24 |
Lotufo-Neto F, Trivedi M, Thase ME. 1999. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression. Neuropsychopharmacology 20: 226-247.
DOI
|
25 |
Carradori S, D'Ascenzio M, Chimenti P, Secci D, Bolasco A. 2014. Selective MAO-B inhibitors: a lesson from natural products. Mol. Divers. 18: 219-243.
DOI
|
26 |
Mathew B, Suresh J, Mathew GE, Parasuraman R, Abdulla N. 2014. Plant secondary metabolites - potent inhibitors of monoamine oxidase isoforms. Cent. Nerv. Syst. Agents Med. Chem. 14: 28-33.
DOI
|
27 |
Orhan IE. 2016. Potential of natural products of herbal origin as monoamine oxidase inhibitors. Curr. Pharm. Des. 22: 268-276.
|